In 2023, India's HIV-positive tuberculosis treatment success rate was at a stable value of 73%. The forecast for 2024 to 2028 indicates this rate is expected to remain constant at 73% each year. Over the next five years, no variation is projected, suggesting a stagnation in the treatment success rate.
Future trends to watch for include:
- Advancements in medical technologies or pharmaceuticals that could potentially improve treatment success rates.
- Policy shifts or increased health funding targeting TB and HIV co-infection treatment efficiencies.
- An emphasis on socio-economic factors affecting treatment adherence and success, including access to healthcare services in rural and underserved areas.
